Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion.
Packman
A M
AM
Dermik Laboratories, Inc., Collegeville, Pennsylvania 19426, USA.
Brown
R H
RH
Dunlap
F E
FE
Kraus
S J
SJ
Webster
G F
GF
D000152:Acne Vulgaris / Q000188:drug therapy*; D000287:Administration, Topical; D000328:Adult; D000704:Analysis of Variance; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001585:Benzoyl Peroxide / Q000008:administration & dosage / Q000627:therapeutic use*; D002981:Clindamycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D007641:Keratolytic Agents; D002981:Clindamycin; D004917:Erythromycin; C007084:clindamycin phosphate; D001585:Benzoyl Peroxide